Vencel Somai

June 16, 2020

Vencel is currently developing treatment response monitoring sequences for hyperpolarized 13C and deuterium MRIS in preclinical environment and is also responsible for their clinical translation. The hyperpolarized project is a collaboration with the Department of Radiology and aims at more efficient, clinically feasible imaging of hyperpolarized substrates and their downstream metabolites while the deuterium work focuses on MR detection of newly developed 2H-labelled biomarkers.

 

Vencel Somai
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect